FDA’s new rare disease framework aims to leverage patient voices for better innovation
The voices of patients with a rare disease are sometimes heard by the FDA—at listening sessions and during advisory committee…
The voices of patients with a rare disease are sometimes heard by the FDA—at listening sessions and during advisory committee…